Specifications
Species Reactivity
Mouse; Human; Rat; Chicken; Pig; Horse; Rabbit; Sheep
Immunogen
KLH conjugated synthetic peptide derived from human Golgi Complex: 321-420/1179
Applications
Application Notes
IHC-P: 1:100-500
IHC-F: 1:100-500
IF: 1:100-500
General Notes
This product (Catalog No. DPABH-25277) is a rabbit-derived IgG polyclonal antibody raised against human GLG1, targeting the amino acid region 321–420 of the protein. This antibody exhibits cross-reactivity with GLG1 from mouse, rat, chicken, pig, horse, rabbit, and sheep. It has been affinity purified by Protein A. Predicted to enable fibroblast growth factor binding activity. Predicted to act upstream of or within several processes, including negative regulation of protein processing; negative regulation of transforming growth factor beta receptor signaling pathway; and regulation of chondrocyte differentiation. Located in Golgi apparatus.
DPABH-25277 is suitable for use in IHC-P (1:100–1:500), IHC-F (1:100–1:500), IF (immunofluorescence) (1:100–1:500) applications.
DPABH-25277 is supplied as a liquid formulation in 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. For long-term storage, keep at −20 °C. For short-term use, store at 2–8 °C. Avoid repeated freeze–thaw cycles to maintain antibody integrity and performance.
Target
Alternative Names
AI593353; AW537898; CFR 1; CFR-1; CFR1; Cysteine rich fibroblast growth factor receptor; Cysteine-rich fibroblast growth factor receptor; DKFZp686L08213; E selectin ligand 1; E-selectin ligand 1; ESL 1; ESL-1; ESL1; FLJ23319; FLJ23967; FLJ32797; GLG1; Golgi apparatus protein 1; Golgi sialoglycoprotein MG 160; Golgi sialoglycoprotein MG-160; GSLG1_HUMAN; MG 160; MG160; Selel; Slectin, endothelial cell, ligand
Citations
Publication ()
Have you cited DPABH-25277 in a publication?
Let us know and earn a reward for your research.